A wide range of evidence has identified reduced phosphorylation levels and elevated GSK3β protein levels in the brains of schizophrenic patients, indicating hyper-activity of GSK3β in schizophrenia [19,20]. The gene discussed is GSK3B; the disease is schizophrenia.